We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$554M
AUM Growth
+$4.17M
Cap. Flow
+$7.88M
Cap. Flow %
1.42%
Top 10 Hldgs %
26.03%
Holding
1,227
New
194
Increased
251
Reduced
267
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 30.09%
2 Industrials 12.78%
3 Financials 12.07%
4 Real Estate 9.38%
5 Consumer Discretionary 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIVE
1076
HIVE Digital Technologies
HIVE
$848M
$627 ﹤0.01%
330
SSK
1077
REX-Osprey SOL + Staking ETF
SSK
$71.9M
$596 ﹤0.01%
+53
New +$772
DCH
1078
Dauch Corp
DCH
$1.31B
$593 ﹤0.01%
100
BHC icon
1079
Bausch Health
BHC
$1.68B
$589 ﹤0.01%
109
COKE icon
1080
Coca-Cola Consolidated
COKE
$11.7B
$575 ﹤0.01%
3
XDEC icon
1081
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$201M
$564 ﹤0.01%
14
-8
-36% -$327
ACRS icon
1082
Aclaris Therapeutics
ACRS
$764M
$563 ﹤0.01%
150
AVA icon
1083
Avista
AVA
$3.47B
$562 ﹤0.01%
+14
New +$565
GIL icon
1084
Gildan
GIL
$9.52B
$557 ﹤0.01%
10
WOOF icon
1085
Petco
WOOF
$731M
$556 ﹤0.01%
200
CRBG icon
1086
Corebridge Financial
CRBG
$13.9B
$549 ﹤0.01%
+23
New +$644
SPSM icon
1087
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$532 ﹤0.01%
11
NMAX
1088
Newsmax Inc
NMAX
$1B
$522 ﹤0.01%
100
STM icon
1089
STMicroelectronics
STM
$48.8B
$518 ﹤0.01%
+15
New +$469
CORT icon
1090
Corcept Therapeutics
CORT
$10.4B
$513 ﹤0.01%
13
MPT
1091
Medical Properties Trust
MPT
$2.87B
$491 ﹤0.01%
106
-5
-5% -$26
RARE icon
1092
Ultragenyx Pharmaceutical
RARE
$2.72B
$482 ﹤0.01%
23
MGNX icon
1093
MacroGenics
MGNX
$263M
$462 ﹤0.01%
160
-848
-84% -$1.81K
ALDX icon
1094
Aldeyra Therapeutics
ALDX
$98.3M
$448 ﹤0.01%
265
VOOV icon
1095
Vanguard S&P 500 Value ETF
VOOV
$6.53B
$426 ﹤0.01%
2
OMEX icon
1096
Odyssey Marine Exploration
OMEX
$43.5M
$417 ﹤0.01%
+500
New +$850
WVE icon
1097
Wave Life Sciences
WVE
$1.11B
$412 ﹤0.01%
57
COTY icon
1098
Coty
COTY
$2.24B
$402 ﹤0.01%
200
PDSB icon
1099
PDS Biotechnology
PDSB
$39.4M
$396 ﹤0.01%
655
SPYG icon
1100
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.1B
$392 ﹤0.01%
4

Similar funds

Truvestments Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Truvestments Capital held 1,227 positions worth $554M, up 0.76% from $550M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Truvestments Capital's Q1 2026 filing shows 194 new, 251 increased, 267 reduced and 50 closed positions. Its largest new stake was Lincoln National: 44,885 shares worth $1.59M. The largest sale was NXP Semiconductors, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Industrials and Financials.

  • Truvestments Capital's largest Q1 2026 buy was Lincoln National: 44,885 shares worth $1.59M.
  • Truvestments Capital added most to Dell in Q1 2026, an estimated $1.91M increase.
  • Truvestments Capital's biggest Q1 2026 reduction was NXP Semiconductors, cutting an estimated $1.93M.
  • Truvestments Capital fully exited Semler Scientific in Q1 2026, selling an estimated $837K.
  • Truvestments Capital's ten largest holdings make up 26% of its $554M portfolio in Q1 2026.
  • Truvestments Capital opened 194 new positions and closed 50 in Q1 2026.
  • Truvestments Capital's portfolio value rose 0.76% quarter-over-quarter to $554M.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.